scholarly journals Is intestinal metaplasia the point of no return in the progression of gastric carcinogenesis?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Si-Ran Wu ◽  
Yu-Hao Liu ◽  
Yong-Quan Shi
1998 ◽  
Vol 114 ◽  
pp. A676 ◽  
Author(s):  
IA Scotiniotis ◽  
T Rokkas ◽  
EE Furth ◽  
JW Plotkin ◽  
B Rigas ◽  
...  

2016 ◽  
Vol 16 (9) ◽  
pp. 1079-1084
Author(s):  
Ye Han ◽  
Qiaoming Zhi ◽  
Xiaofeng Xue ◽  
Bin Yuan ◽  
Hong Zhao ◽  
...  

2016 ◽  
Vol 51 (10) ◽  
pp. 949-960 ◽  
Author(s):  
Soichiro Sue ◽  
Wataru Shibata ◽  
Eri Kameta ◽  
Takeshi Sato ◽  
Yasuaki Ishii ◽  
...  

2016 ◽  
Vol 34 (4_suppl) ◽  
pp. 28-28
Author(s):  
Ji Hyun Song ◽  
Sang Gyun Kim ◽  
Eun Hyo Jin ◽  
Joo Hyun Lim ◽  
Sun Young Yang

28 Background: Atrophic gastritis and intestinal metaplasia were considered as premalignant lesions. The prevalence of chronic atrophic gastritis is very high in Korea. The aims of this study were to evaluate the risk factors of gastric carcinogenesis in underlying gastric mucosal atrophy. Methods: A total of 10187 subjects underwent upper gastrointestinal endoscopy for health checkup between 2003 and 2004 were enrolled in this retrospective cohort study. Follow-up endoscopy was performed between 2005 and 2014. Atrophic gastritis and intestinal metaplasia were assessed according to the Kimura-Takemoto classification by endoscopy. Helicobacter pylori (Hp) was evaluated by serum IgG antibody. Results: The number of atrophic gastritis was 3716 (36.5%) in baseline endoscopy, and 2146 were undergone follow-up endoscopy (82.8±38.3month); 1139 showed aggravation of atrophy and 1007 showed no change. A total of 71 subjects were diagnosed as gastric neoplasms (34 adenoma, 37 carcinoma). Age (HR = 1.019, 95%CI 1.010-1.028), alcohol intake (HR = 1.002, 95%CI 1.001-1.002), Salt intake (HR = 1.295, 95%CI 1.038-1.617) and Hp infection (HR = 1.584, 95%CI 1.220-2.057) were associated with aggravation of mucosal atrophy. The risk factors for gastric neoplasm in underlying mucosal atrophy were age (HR = 1.041, 95%CI 1.004-1.079), alcohol intake (HR = 1.003, 95% CI 1.001-1.005), Salt intake (HR = 2.553, 95% CI 1.141-5.712), Extent of mucosal atrophy (HR = 2.375, 95% CI 1.201-4.695 in C3-O1; HR = 4.255, 95% CI 1.612-11.229 in O2-O3), and intestinal metaplasia (HR = 2.599, 95% CI 1.286-5.251). Conclusions: Hp was a risk factor for aggravation of atrophy, but not for gastric neoplasm. Salt intake, extent of mucosal atrophy, and intestinal metaplasia were important risk factors for gastric neoplasm.


2021 ◽  
Vol 94 (1) ◽  
pp. 199 ◽  
Author(s):  
Tsutomu Nishida ◽  
Dai Nakamatsu ◽  
Kengo Matsumoto ◽  
Masashi Yamamoto

Author(s):  
Kichul Yoon ◽  
Nayoung Kim

There has been an accumulation of data regarding the chemopreventive effects of <i>Helicobacter pylori</i> (<i>H. pylori</i>) eradication. However, it remains unclear how <i>H. pylori</i> infection causes gastric cancer (GC) and how <i>H. pylori</i> eradication can prevent GC. Atrophic gastritis (AG) and intestinal metaplasia (IM) are known as precancerous lesions which mainly lead to intestinal-type GC but to some extent, can also lead to diffuse-type GC. The most important mechanism of AG/IM is <i>H. pylori</i>-induced chronic gastritis. Thus, the reversibility of AG and IM by <i>H. pylori</i> eradication therapy is very important in the prevention of GC. There have been many studies providing data supporting the improvement of AG by the eradication of <i>H. pylori</i> to some extent. In contrast, IM has been regarded as “the point of no return.” However, more recent studies have implied the improvement of IM after eradication, suggesting the importance of early eradication therapy in reversible histological status. In this review, we focused on the reversibility of AG and IM by <i>H. pylori</i> eradication and tried to investigate the predicting factors for the improvement of AG and IM including age, sex, smoking, and diet, as well as <i>H. pylori</i> infection.


Sign in / Sign up

Export Citation Format

Share Document